Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             47 results found
no title author magazine year volume issue page(s) type
1 Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approaches Hanna, Debra
 2017
 56 C p. 208-211
4 p.
 article
2 A literary approach to tuberculosis: lessons learned from Anton Chekhov, Franz Kafka, and Katherine Mansfield Vilaplana, Cristina
 2017
 56 C p. 283-285
3 p.
 article
3 Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm Rao, Martin
 2017
 56 C p. 221-228
8 p.
 article
4 Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings Sotgiu, Giovanni
 2017
 56 C p. 190-193
4 p.
 article
5 A tuberculosis biomarker database: the key to novel TB diagnostics Yerlikaya, Seda
 2017
 56 C p. 253-257
5 p.
 article
6 Classifying new anti-tuberculosis drugs: rationale and future perspectives Tiberi, Simon
 2017
 56 C p. 181-184
4 p.
 article
7 De-isolation of patients with pulmonary tuberculosis after start of treatment — clear, unequivocal guidelines are missing Petersen, Eskild
 2017
 56 C p. 34-38
5 p.
 article
8 Editorial Board 2017
 56 C p. i-
1 p.
 article
9 Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings Alabi, Abraham Sunday
 2017
 56 C p. 81-84
4 p.
 article
10 European policies in the management of tuberculosis among migrants D’Ambrosio, Lia
 2017
 56 C p. 85-89
5 p.
 article
11 Evaluating the impact of healthcare provider training to improve tuberculosis management: a systematic review of methods and outcome indicators used Wu, Shishi
 2017
 56 C p. 105-110
6 p.
 article
12 Experimental animal modelling for TB vaccine development Cardona, Pere-Joan
 2017
 56 C p. 268-273
6 p.
 article
13 Exploring tuberculosis by molecular tests on DNA isolated from smear microscopy slides Rakotosamimanana, Niaina
 2017
 56 C p. 248-252
5 p.
 article
14 Funding for tuberculosis research—an urgent crisis of political will, human rights, and global solidarity Frick, Mike
 2017
 56 C p. 21-24
4 p.
 article
15 Health systems in the Republic of Congo: challenges and opportunities for implementing tuberculosis and HIV collaborative service, research, and training activities Linguissi, Laure Stella Ghoma
 2017
 56 C p. 62-67
6 p.
 article
16 High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers Weiner, January
 2017
 56 C p. 258-262
5 p.
 article
17 Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays Ferrara, Giovanni
 2017
 56 C p. 167-175
9 p.
 article
18 Imaging in extrapulmonary tuberculosis Gambhir, Sanjay
 2017
 56 C p. 237-247
11 p.
 article
19 Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays Valentini, Davide
 2017
 56 C p. 155-166
12 p.
 article
20 Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014–2015 Ebola virus disease outbreak in West Africa Ansumana, Rashid
 2017
 56 C p. 101-104
4 p.
 article
21 Improving access to tuberculosis preventive therapy and treatment for children Marais, Ben J.
 2017
 56 C p. 122-125
4 p.
 article
22 Insights gained from ancient biomolecules into past and present tuberculosis—a personal perspective Donoghue, Helen D.
 2017
 56 C p. 176-180
5 p.
 article
23 Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis Zumla, Alimuddin
 2017
 56 C p. 126-129
4 p.
 article
24 Less research on tuberculosis than HIV and malaria when research agendas are poorly coordinated: a systematic review of research outputs from Cambodia Khan, Mishal
 2017
 56 C p. 25-29
5 p.
 article
25 Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model Rao, Martin
 2017
 56 C p. 274-282
9 p.
 article
26 New tuberculosis drug leads from naturally occurring compounds Quan, Diana
 2017
 56 C p. 212-220
9 p.
 article
27 Novel approaches to tuberculosis vaccine development Kaufmann, Stefan H.E.
 2017
 56 C p. 263-267
5 p.
 article
28 Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities McAnaw, S.E.
 2017
 56 C p. 194-199
6 p.
 article
29 Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette–Guérin vaccination Valentini, Davide
 2017
 56 C p. 140-154
15 p.
 article
30 Preventive therapy for latent tuberculosis infection—the promise and the challenges Fox, G.J.
 2017
 56 C p. 68-76
9 p.
 article
31 Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade Cazabon, Danielle
 2017
 56 C p. 111-116
6 p.
 article
32 Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action McNerney, Ruth
 2017
 56 C p. 130-135
6 p.
 article
33 Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia Vashakidze, Sergo
 2017
 56 C p. 200-207
8 p.
 article
34 Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective Kendall, Emily A.
 2017
 56 C p. 185-189
5 p.
 article
35 Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable? Centis, Rosella
 2017
 56 C p. 30-33
4 p.
 article
36 Status of Tuberculosis services in Indian Prisons Prasad, Banuru Muralidhara
 2017
 56 C p. 117-121
5 p.
 article
37 Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy Nagu, Tumaini
 2017
 56 C p. 136-139
4 p.
 article
38 Tackling TB in low-incidence countries: improving diagnosis and management in vulnerable populations Heuvelings, C.C.
 2017
 56 C p. 77-80
4 p.
 article
39 The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications Girardi, Enrico
 2017
 56 C p. 45-53
9 p.
 article
40 The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains McBryde, Emma S.
 2017
 56 C p. 14-20
7 p.
 article
41 Tuberculosis and hypertension—a systematic review of the literature Seegert, Anneline Borchsenius
 2017
 56 C p. 54-61
8 p.
 article
42 Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy Nagu, Tumaini J.
 2017
 56 C p. 39-44
6 p.
 article
43 Tuberculosis eradication versus control Schito, Marco
 2017
 56 C p. 10-13
4 p.
 article
44 Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries Craig, G.M.
 2017
 56 C p. 90-100
11 p.
 article
45 Turning the tide against tuberculosis Padayatchi, Nesri
 2017
 56 C p. 6-9
4 p.
 article
46 Ultrasound for patients in a high HIV/tuberculosis prevalence setting: a needs assessment and review of focused applications for Sub-Saharan Africa Heller, Tom
 2017
 56 C p. 229-236
8 p.
 article
47 World TB Day 2017: Advances, Challenges and Opportunities in the “End-TB” Era Petersen, Eskild
 2017
 56 C p. 1-5
5 p.
 article
                             47 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands